Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report

被引：1

作者：

Chin, Simone ^{[1
]}

Fox, Lucy ^{[2
]}

Majumdar, Avik ^{[1
,3
]}

Oliver, Mark ^{[4
]}

Choy, Matthew C. ^{[1
,3
]}

De Cruz, Peter ^{[1
,3
]}

机构：

[1] Austin Hlth, Dept Gastroenterol, Melbourne, Vic, Australia

[2] Austin Hlth, Dept Haematol, Melbourne, Vic, Australia

[3] Univ Melbourne, Austin Acad Ctr, Dept Med, Melbourne, Vic, Australia

[4] Royal Childrens Hosp, Dept Gastroenterol, Melbourne, Vic, Australia

来源：

INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷 / 08期

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

INFLAMMATORY-BOWEL-DISEASE; RISK;

D O I：

10.1093/ibd/izae091

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pneumocystis jirovecii is a ubiquitous, unicellular fungus that can cause pneumonia (PJP) in immunosuppressed individuals. We report the first case of PJP complicating upadacitinib use for ulcerative colitis. This report is of clinical relevance given the widespread uptake of JAK inhibition.

引用

页码：1435 / 1436

页数：2

共 8 条

[1] Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression [J].

Cotter, Thomas G. ;

Gathaiya, Nicola ;

Catania, Jelena ;

Loftus, Edward V., Jr. ;

Tremaine, William J. ;

Baddour, Larry M. ;

Harmsen, W. Scott ;

Zinsmeister, Alan R. ;

Sandborn, William J. ;

Limper, Andrew H. ;

Pardi, Darrell S. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) :850-856

[2]

Grigoropoulos Ioannis, 2019, Mediterr J Rheumatol, V30, P167, DOI 10.31138/mjr.30.3.167

[3]

Jones L., 2021, AM J RESP CRIT CARE, V203, pA2119, DOI [10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2119, DOI 10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A2119]

[4] ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease (Publication with Expression of Concern) [J].

Kucharzik, T. ;

Ellul, P. ;

Greuter, T. ;

Rahier, J. F. ;

Verstockt, B. ;

Abreu, C. ;

Albuquerque, A. ;

Allocca, M. ;

Esteve, M. ;

Farraye, F. A. ;

Gordon, H. ;

Karmiris, K. ;

Kopylov, U. ;

Kirchgesner, J. ;

MacMahon, E. ;

Magro, F. ;

Maaser, C. ;

de Ridder, L. ;

Taxonera, C. ;

Toruner, M. ;

Tremblay, L. ;

Scharl, M. ;

Viget, N. ;

Zabana, Y. ;

Vavricka, S. .

JOURNAL OF CROHNS & COLITIS, 2021, 15 (06) :879-913

[5] Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease [J].

Long, Millie D. ;

Martin, Christopher ;

Sandler, Robert S. ;

Kappelman, Michael D. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (02) :240-248

[6]

Ng SC, 2017, J CROHNS COLITIS, V11, pS41

[7] Pneumocystis Jiroveci Pneumonia in Patients with Inflammatory Bowel Disease: A Survey of Prophylaxis Patterns Among Gastroenterology Providers [J].

Okafor, Philip N. ;

Wasan, Sharmeel K. ;

Farraye, Francis A. .

INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) :812-817

[8] Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease-a Case Series [J].

Vieujean, S. ;

Moens, A. ;

Hassid, D. ;

Rothfuss, K. ;

Savarino, E. ;

Vavricka, S. R. ;

Reenaers, C. ;

Jacobsen, B. ;

Allez, M. ;

Ferrante, M. ;

Rahier, J. F. .

JOURNAL OF CROHNS & COLITIS, 2022, :472-479

← 1 →